• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    Visual acuity after intravitreal ranibizumab with and without laser therapy in the treatment of macular edema due to branch retinal vein occlusion: a 12-month retrospective analysis

    2021-11-08 01:45:30ReikoUmeyaKoichiOnoToshimitsuKasuga
    International Journal of Ophthalmology 2021年10期

    Reiko Umeya, Koichi Ono, Toshimitsu Kasuga

    1Department of Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo 136-0075, Japan

    2Department of Ophthalmology, Juntendo University School of Medicine, Tokyo 113-8421, Japan

    Abstract

    ● KEYWORDS: interaction; ranibizumab; laser; macular edema; branch retinal vein occlusion

    INTRODUCTION

    Since it was first described in 1984, laser photocoagulation has been used to treat macular edema (ME) associated with branch retinal vein occlusion (BRVO)[1]. More recently,the BRAVO study, which investigated the treatment of ME following BRVO[2-3], showed that intravitreal injection of the vascular endothelial growth factor (VEGF) inhibitor ranibizumab (IVR) was a safe and effective treatment for BRVO-associated ME. This treatment has also been widely used in Japan, where it was approved for coverage under the National Health Insurance system in August 2013.The BRIGHTER study showed that at six months after commencing treatment, IVR with or without laser therapy was significantly better in terms of efficacy and safety than laser therapy alone[4-5]. The multicenter investigations conducted to date point to intravitreal anti-VEGF therapy as a reasonable first-choice treatment for BRVO-associated ME. However,most prospective randomized controlled trials to date have been sponsored by the pharmaceutical industry. In the BRAVO study, patients in the 0.5 mg ranibizumab group underwent an average of 8.4 intravitreal injections per year[3]; in clinical practice, such frequent intravitreal injections would place a heavy economic burden on the patient. Another prospective study examined combined treatment with macular grid photocoagulation and anti-VEGF drugs to reduce the number of intravitreal injections per patient; however, the combination did not affect visual acuity[6]. Despite this, 14/39 (35.9%)retinal experts in clinical practice in Japan opted for anti-VEGF and laser therapy in patients with recurrent ME due to BRVO[7].This suggests that, at least in some cases, combination therapy may have some beneficial effects. Therefore, the purpose of the present study was to assess the interaction between laser therapy and IVR retrospectively.

    SUBJECTS AND METHODS

    Ethical Approval Each patient provided written informed consent before treatment with laser, sub-Tenon’s capsule injection of triamcinolone (STTA), or IVR at our hospital. The study protocol was reviewed and approved by the Institutional Ethics Committee. This study was conducted in accordance with the Declaration of Helsinki, and no personal information is reported.

    Study Design and Patients This retrospective, observational,single-institution, case-comparison series was performed to analyze visual outcomes 1y after treatment of ME secondary to BRVO. We reviewed outpatient clinical records between June 2002 and June 2019, searching for data using the diagnostic term “retinal vascular occlusion” (International Classification of Diseases-10 code H34). Patients seen at our hospital from June 2002 to June 2019 were included if they met the following criteria: 1) a diagnosis of retinal vascular occlusion; 2) fluorescein angiography (FA) and/or optical coherence tomography (OCT)of the fundus; 3) at least 12mo of follow-up; 4) presence of ME. Exclusion criteria were 1) incorrect diagnosis or incomplete clinical record; 2) central retinal vein occlusion;3) follow-up of less than 12mo; 4) intravitreal bevacizumab injection (IVB); 5) intravitreal aflibercept injection (IVA).

    Clinical Analysis and Outcome Measures BRVO-associated ME was diagnosed based on FA and/or OCT findings.All subjects underwent comprehensive ophthalmological examination, including best corrected visual acuity (BCVA),retinal structure evaluation using FA (Topcon Medical Systems, Inc., Oakland, New Jersey, USA), and/or OCT(Cirrus high-definition OCT; carl Zeiss, Dublin, CA, USA).The reported therapeutic outcome was based on change in visual acuity between initial presentation and 12-month follow-up. BCVA was measured at 5 m on a standard Japanese fractional visual acuity chart (Distant Test Chart, LANDOLT,Handaya, Tokyo, Japan). The logarithmic minimal angle of resolution (logMAR) was calculated from the decimal visual acuity. OCT was introduced in August 2008, and we quantified the fovea thickness in subsequent cases. Possible confounding factors for visual outcomes were selected in accordance with results from previous studies and included age[8], history of systemic hypertension, diabetes mellitus[9], current or past smoking history, and foveal hemorrhage[10]. A history of systemic hypertension, diabetes mellitus, and/or smoking was established from the clinical records.

    Treatments After diagnosis of ME associated with BRVO,informed consent was obtained from each patient, and treatment provided at the discretion of each doctor. Treatment methods included laser therapy, IVR (Lucentis?, 0.5 mg in 0.05 mL; Genentech, San Francisco, CA, USA), sub-Tenon’s capsule injection of triamcinolone (STTA; Kenacort?, 20 mg; Bristol-Myers Squibb, Princeton, NJ, USA)[11], or a combination thereof, as well as some cases that were observed without intervention. Coagulation conditions requiring local coagulation for blood vessel dilation, and grid coagulation for diffuse leakage, were at the discretion of each doctor and considered laser treatment in the present study. Since 2013,when ranibizumab was approved for insurance in Japan, IVR has been implemented for OCT with central retinal thickness over 300 μm. Combination therapy was administered at the discretion of each doctor.

    Statistical Analysis Visual acuity and central foveal thickness (CFT) were expressed as mean±standard deviation(SD). Decimal acuity was converted to logMAR units for statistical analysis. A pairedt-test was performed to evaluate the difference in visual acuity before and after treatment.Multivariate logistic regression was used to estimate the odds ratio (OR) and 95% confidence interval (CI). Age, sex, history of hypertension, diabetes mellitus, smoking history, and foveal hemorrhage were considered confounders. We examined the interaction of treatment methods that contributed to the improvement in visual acuity by using multivariate Logistic regression analysis with the interaction terms.P<0.05 was considered statistically significant. All statistical analyses were performed in STATA/SE 15.1 for windows (Stata Corp.,College Station, TX, USA).

    RESULTS

    Baseline Characteristics and Patient Demographics A patient selection flowchart for this study is shown in Figure 1.We included patients diagnosed with retinal vascular occlusion at our hospital from June 2002 to June 2019. From 555 records identified, we excluded records with errors in registration or documentation on clinical charts (n=60); patients with central retinal vein occlusion (n=174), late-stage BRVO (n=129),BRVO without ME (n=30), and BRVO with <12mo of followup (n=55), patients who received IVB (n=33), and patients who received IVA (n=1). Detailed patient profile and treatment history is presented in Table 1. We included 73 patients (34 men, 39 women; 73 eyes) with BRVO-associated ME, aged 33-93y (mean±SD, 69.4±12.1y). Twenty patients received laser monotherapy, 12 received IVR monotherapy, 4 received STTA monotherapy, 4 received IVR+STTA, 8 received IVR+laser,4 received STTA+laser, and 3 received IVR+STTA+laser.Eighteen patients were observed who did not receive treatment throughout the follow-up period.

    Figure 1 Subject selection flowchart Patients seen at our hospital from June 2002 to June 2019 were included if they had a diagnosis of retinal vascular occlusion. BRVO: Branch retinal vein occlusion;CRVO: Central retinal vein occlusion; ME: Macular edema.

    Table 1 Clinical characteristics in patients with BRVO mean±SD

    Visual Acuity and Central Foveal Thickness Table 2 shows the course of visual acuity and central retinal thickness for each treatment. Dunn’s multiple-comparison test for stochastic dominance using Bonferroni correction, showed no difference in BCVA among groups at baseline. The BCVA in the IVR monotherapy, laser monotherapy, and STTA+laser groups were significantly increased (P<0.001, <0.001, and =0.019,respectively). OCT was performed in 38 of 73 cases (52.1%)with a significant reduction in CFT at 12mo (317.2±165.1vs537.6±197.5 μm,P<0.0001). Table 2 shows visual acuity and central foveal thickness at baseline and after treatment in each group.

    Factors Associated with Visual Acuity Improvement Table 3 shows the ORs of each predictor of visual acuity improvement. In simple Logistic regression models, the factor associated with visual improvement was IVR (crude OR:3.05, 95%CI: 1.12-8.30,P=0.029). After adjusting for all other variables, IVR remained the significant factor (adjusted OR:3.89, 95%CI: 1.25-12.1,P=0.019). There was no significant interaction between laser and IVR (adjusted OR: 0.07, 95%CI:0.01-0.75,P=0.029; Table 4).

    DISCUSSION

    Our retrospective analysis of visual outcomes after 12mo in patients treated for ME due to BRVO showed that laser and IVR improved visual acuity; however, there was no significant interaction between these treatments. Before the introduction of anti-VEGF therapy, grid laser photocoagulation was the standard treatment for ME due to BRVO[1]. Today, anti-VEGF therapy is widely accepted as the treatment of choice for BRVO-associated ME, based on prospective randomized controlled trials[2-4].

    Two previous large retrospective cohort studies[12-13]have described visual improvements after anti-VEGF treatment.Within these cases, a small number (23/205[12]and 20/177[13])received laser therapy in combination with anti-VEGF treatment, but the interaction of these treatments was not analyzed statistically. The BRAVO study[3]prospectively compared visual outcomes after treatment between two groups; grid laser photocoagulation was used in 20% of the IVR group and 55% of the sham group. However, the study did not examine whether grid laser photocoagulation combined with IVR had any therapeutic effects. In another study, Tanet al[14]compared the efficacy of IVR for BRVO-associated ME for 12mo between patients who received IVR for six consecutive months then as needed for another six months, and patients who received sham injections for 12mo. Grid laser photocoagulation was performed at 13 and 25wk in 2 of 15 cases in the IVR group, and in all 21 cases of the sham group.Their results showed that, compared to the sham group, the IVR group exhibited significant and sustained improvements invisual acuity and anatomical outcomes after 12mo of treatment.However, they could not demonstrate that the combination of laser and ranibizumab therapy resulted in higher efficacy than ranibizumab monotherapy. In the RELATE study,subjects randomly assigned to treatment with 0.5 or 2.0 mg of ranibizumab every 4wk for 24wk were then re-randomized to receive only ranibizumab+laser orpro re nataranibizumab[15].Significant improvements in BCVA were reported within the first two years in the group that received additional laser treatment, but this significance disappeared in later follow-ups.The authors concluded that the addition of laser therapy neither increased edema resolution nor reduced the total number of ranibizumab injections, so there was no long-term benefit. In the BRIGHTER study[4], one group received IVR injections for at least three consecutive months initially, followed by an asneeded regimen, and was compared with an IVR+laser group and a laser monotherapy group; the IVR groups, with or without laser, showed significantly better visual results after six months than the laser monotherapy group, with no difference between the IVR and IVR+laser groups. In other words, the beneficial effects of additional laser therapy could not be demonstrated.Overall, these randomized controlled trials[3-4,14-15]indicated that adding laser treatment to IVR had no beneficial effect on BRVO edema. However, a combination of IVB and laser photocoagulation was reported to reduce the number of bevacizumab doses[16], although the interaction between IVR and laser treatment had not been studied to date.

    Table 2 Change in visual acuity and central retinal thickness from baseline to 12mo mean±SD

    Table 3 Odds ratios of visual acuity recovery obtained by Logistic regression analysis without interaction terms

    Table 4 Adjusted odds ratios using an interaction model

    The strength of the present study is the inclusion of patients across the time period when laser treatment was the main treatment focus and the current time period when anti-VEGF treatment is the main focus. Therefore, by including patients treated with laser monotherapy before the introduction and approval of the anti-VEGF drug ranibizumab (Lucentis?),the likelihood of selection bias is reduced. As a result, in the Logistic analysis model without interaction terms, the factor related to visual acuity improvement was IVR, with no interaction between laser and IVR. The reason for this may be that our study included cases with long-duration ME before intervention, as well as cases of severe, refractory, and recurrent ME, reflecting real-world clinical conditions.

    There are some limitations to our study, including the retrospective nature of the study. At our hospital (Juntendo Tokyo Koto Geriatric Medical Center), our patients have an older demographic, and it is difficult to conduct prospective clinical trials due to cognitive decline and physical dysfunction.Another limitation is the use of clinical records, with a strong possibility of introducing bias due to deficits in documentation and history-taking as well as patient misclassification. Also,selection bias may have been introduced as patients and ophthalmologists were not blinded to the treatment assigned,with more patients with poor response to laser monotherapy being assigned to IVR+laser. In addition, various types of laser treatment were included, and it was sometimes difficult to determine from medical records whether a grid laser,non-perfusion area laser, or both, had been used. Although a randomized controlled trial would be ideal, the doubleblind method would require the use of ethically questionable methods such as sham vitreous injection or sham laser, and unlike traditional treatments does not respect the patient’s self-determination. Last, the sample size was small (n=73).This is because older patients are difficult to follow for more than 12mo, and this study does not include patients treated with IVB or IVA. Due to the small sample size, we had to reduce the number of confounding factors. Previous studies included ethnicity, high hematocrit[17-18], and the presence of hyperlipidemia, cardiovascular disease, apoplexy, renal disease, sleep apnea syndrome[19], and primary open-angle glaucoma[20]. Other studies showed that factors related to poor visual outcome were age, time to disease onset, visual acuity at initiation of treatment[5], and the presence of sub-foveal hemorrhage[9]. The small sample size in the present study was likely insufficient to test the effects of these all potential confounding factors.

    In conclusion, IVR therapy significantly improved the visual acuity of patients with BRVO-associated ME, and no interaction was observed between laser and IVR therapies.However, in routine clinical situations, ME can recur after IVR therapy, and in some cases requires laser photocoagulation.In future studies, it would be worth identifying factors associated with lower doses and shorter duration of anti-VEGF administration, and even those associated with ultimate treatment cessation.

    ACKNOWLEDGEMENTS

    Conflicts of Interest:Umeya R, None; Ono K, None;Kasuga T, None.

    国产高清视频在线播放一区 | 日本vs欧美在线观看视频| 后天国语完整版免费观看| 夜夜骑夜夜射夜夜干| 人妻一区二区av| 国产三级黄色录像| 国产精品亚洲av一区麻豆| 看免费成人av毛片| 亚洲精品国产av蜜桃| 亚洲精品久久午夜乱码| 天天躁夜夜躁狠狠久久av| 国产成人一区二区在线| 丰满少妇做爰视频| svipshipincom国产片| 国产免费福利视频在线观看| 欧美+亚洲+日韩+国产| 国产精品人妻久久久影院| 日本av手机在线免费观看| 久久久久久久久久久久大奶| 国产日韩欧美在线精品| 另类精品久久| 国产精品久久久久久精品古装| 精品少妇久久久久久888优播| 欧美黄色片欧美黄色片| 大码成人一级视频| 90打野战视频偷拍视频| 大码成人一级视频| 国产又色又爽无遮挡免| 亚洲精品一卡2卡三卡4卡5卡 | 黄色毛片三级朝国网站| 美女午夜性视频免费| 涩涩av久久男人的天堂| 亚洲精品第二区| 两人在一起打扑克的视频| 午夜福利免费观看在线| 亚洲国产精品国产精品| 一本久久精品| 日日夜夜操网爽| 男人操女人黄网站| 国产av精品麻豆| 久久久欧美国产精品| 飞空精品影院首页| 久久久久久久久免费视频了| 午夜激情av网站| 性色av乱码一区二区三区2| 深夜精品福利| 国产一级毛片在线| 国产精品一区二区精品视频观看| 午夜福利影视在线免费观看| 啦啦啦中文免费视频观看日本| 99香蕉大伊视频| 国产成人精品无人区| videosex国产| 亚洲国产日韩一区二区| 日韩精品免费视频一区二区三区| 日韩制服丝袜自拍偷拍| 亚洲欧美激情在线| 精品少妇一区二区三区视频日本电影| 天天躁日日躁夜夜躁夜夜| 在线观看国产h片| 男女边摸边吃奶| 50天的宝宝边吃奶边哭怎么回事| 99热国产这里只有精品6| 黑丝袜美女国产一区| 日韩,欧美,国产一区二区三区| 亚洲国产毛片av蜜桃av| 热99国产精品久久久久久7| 中国国产av一级| 最黄视频免费看| 久久99精品国语久久久| 久久毛片免费看一区二区三区| 国产日韩欧美视频二区| 王馨瑶露胸无遮挡在线观看| 久久国产精品人妻蜜桃| 女人精品久久久久毛片| 精品国产乱码久久久久久小说| 十八禁人妻一区二区| 操出白浆在线播放| 啦啦啦 在线观看视频| 免费看不卡的av| 99热全是精品| 欧美人与性动交α欧美软件| 手机成人av网站| 国产无遮挡羞羞视频在线观看| 亚洲图色成人| 18禁国产床啪视频网站| 纵有疾风起免费观看全集完整版| 精品久久久久久久毛片微露脸 | 一级毛片 在线播放| 日本猛色少妇xxxxx猛交久久| 国产成人a∨麻豆精品| a 毛片基地| 黑人巨大精品欧美一区二区蜜桃| 欧美激情 高清一区二区三区| 美女高潮到喷水免费观看| 大片电影免费在线观看免费| 亚洲国产成人一精品久久久| 女性被躁到高潮视频| 国产一级毛片在线| av欧美777| 久久鲁丝午夜福利片| 美女脱内裤让男人舔精品视频| 免费人妻精品一区二区三区视频| 国产男女内射视频| 无限看片的www在线观看| 男人爽女人下面视频在线观看| 国产爽快片一区二区三区| 国产成人系列免费观看| 午夜福利在线免费观看网站| 一级片免费观看大全| 人人妻人人澡人人看| 免费久久久久久久精品成人欧美视频| 亚洲欧美一区二区三区久久| 性色av一级| 无遮挡黄片免费观看| 久久亚洲国产成人精品v| 女性生殖器流出的白浆| 久久久久久久久久久久大奶| 一本色道久久久久久精品综合| 国产精品一区二区在线不卡| 桃花免费在线播放| 九色亚洲精品在线播放| 亚洲av男天堂| 日本av免费视频播放| 19禁男女啪啪无遮挡网站| 精品久久蜜臀av无| 操出白浆在线播放| 叶爱在线成人免费视频播放| 国产成人系列免费观看| 999精品在线视频| 美女视频免费永久观看网站| 亚洲成人免费电影在线观看 | 国产日韩一区二区三区精品不卡| 七月丁香在线播放| 日韩av在线免费看完整版不卡| 国产熟女欧美一区二区| 大香蕉久久网| 高清视频免费观看一区二区| 999久久久国产精品视频| 国产精品免费视频内射| 中国美女看黄片| 亚洲av综合色区一区| 女性被躁到高潮视频| 久久影院123| 一本色道久久久久久精品综合| 国产欧美日韩综合在线一区二区| 观看av在线不卡| 18禁黄网站禁片午夜丰满| 国产欧美日韩综合在线一区二区| 大香蕉久久成人网| 国产成人精品久久久久久| 日韩人妻精品一区2区三区| 如日韩欧美国产精品一区二区三区| 久久精品久久久久久噜噜老黄| 日韩制服骚丝袜av| 日韩一卡2卡3卡4卡2021年| 首页视频小说图片口味搜索 | 亚洲美女黄色视频免费看| 国产免费又黄又爽又色| 少妇精品久久久久久久| 亚洲国产看品久久| 丝袜喷水一区| 欧美人与性动交α欧美软件| 男女高潮啪啪啪动态图| 国产有黄有色有爽视频| 久久精品熟女亚洲av麻豆精品| 国产在线观看jvid| 亚洲 国产 在线| 精品福利观看| 欧美日韩视频高清一区二区三区二| www.精华液| 国产日韩一区二区三区精品不卡| 一级毛片女人18水好多 | 欧美国产精品一级二级三级| 欧美精品av麻豆av| 国产日韩一区二区三区精品不卡| 亚洲欧美日韩高清在线视频 | 免费女性裸体啪啪无遮挡网站| 欧美日韩一级在线毛片| 丁香六月欧美| 成年av动漫网址| 在线天堂中文资源库| 国产精品成人在线| 一级毛片女人18水好多 | 天天添夜夜摸| 最新在线观看一区二区三区 | 老司机在亚洲福利影院| 亚洲欧美精品综合一区二区三区| 亚洲欧美精品综合一区二区三区| 久久青草综合色| 国产1区2区3区精品| 日本av手机在线免费观看| 免费久久久久久久精品成人欧美视频| 大片电影免费在线观看免费| a级毛片在线看网站| 中文字幕人妻丝袜制服| 大型av网站在线播放| 婷婷色av中文字幕| 亚洲精品在线美女| 秋霞在线观看毛片| 免费在线观看影片大全网站 | 国产精品免费大片| 天堂8中文在线网| 91精品伊人久久大香线蕉| 中文字幕精品免费在线观看视频| 777久久人妻少妇嫩草av网站| 精品少妇一区二区三区视频日本电影| 国产精品久久久久久精品古装| 嫩草影视91久久| 波多野结衣av一区二区av| 亚洲视频免费观看视频| 国产91精品成人一区二区三区 | 国产精品一区二区在线不卡| bbb黄色大片| 欧美人与性动交α欧美精品济南到| 一级黄片播放器| 久久精品久久久久久久性| 亚洲精品一区蜜桃| 高清视频免费观看一区二区| avwww免费| 国产成人系列免费观看| 日本91视频免费播放| 91成人精品电影| 欧美人与善性xxx| 日本a在线网址| 制服诱惑二区| 国产一区二区三区av在线| 日韩熟女老妇一区二区性免费视频| 美女脱内裤让男人舔精品视频| 99精国产麻豆久久婷婷| 成人手机av| 亚洲一卡2卡3卡4卡5卡精品中文| bbb黄色大片| 免费观看a级毛片全部| 两人在一起打扑克的视频| 国产高清国产精品国产三级| 丰满迷人的少妇在线观看| 后天国语完整版免费观看| 后天国语完整版免费观看| 国产97色在线日韩免费| 黄色片一级片一级黄色片| 大型av网站在线播放| 黑丝袜美女国产一区| 午夜老司机福利片| 国产亚洲欧美精品永久| 多毛熟女@视频| 99久久综合免费| 777久久人妻少妇嫩草av网站| 国产精品免费视频内射| 国产一区二区 视频在线| 国产99久久九九免费精品| 亚洲欧洲精品一区二区精品久久久| 成人国语在线视频| 女人精品久久久久毛片| 亚洲国产精品一区三区| 午夜日韩欧美国产| 别揉我奶头~嗯~啊~动态视频 | 久久鲁丝午夜福利片| 亚洲欧美色中文字幕在线| 国产淫语在线视频| 一区福利在线观看| 欧美激情极品国产一区二区三区| 99国产综合亚洲精品| 成人亚洲欧美一区二区av| 中国美女看黄片| 久久久精品国产亚洲av高清涩受| 多毛熟女@视频| 91九色精品人成在线观看| 精品亚洲成国产av| 亚洲av欧美aⅴ国产| 中文字幕最新亚洲高清| 在线亚洲精品国产二区图片欧美| 一级毛片黄色毛片免费观看视频| 亚洲精品国产一区二区精华液| 亚洲中文日韩欧美视频| 无遮挡黄片免费观看| 亚洲激情五月婷婷啪啪| 国产99久久九九免费精品| 亚洲av在线观看美女高潮| videosex国产| 欧美中文综合在线视频| 狠狠精品人妻久久久久久综合| 国产熟女欧美一区二区| 国产视频首页在线观看| 亚洲av成人不卡在线观看播放网 | 看免费成人av毛片| 国产麻豆69| 亚洲欧美清纯卡通| 国产成人a∨麻豆精品| av电影中文网址| 亚洲五月色婷婷综合| 男女午夜视频在线观看| www.999成人在线观看| av网站免费在线观看视频| 国产成人av教育| 搡老乐熟女国产| 美女扒开内裤让男人捅视频| 色视频在线一区二区三区| 精品国产国语对白av| 欧美精品av麻豆av| 在线观看免费高清a一片| 亚洲精品日本国产第一区| 国产真人三级小视频在线观看| 在线天堂中文资源库| 久久精品成人免费网站| 各种免费的搞黄视频| 久久精品久久精品一区二区三区| 亚洲一区中文字幕在线| 国产av一区二区精品久久| 欧美成狂野欧美在线观看| 久久 成人 亚洲| 午夜福利视频在线观看免费| 一级,二级,三级黄色视频| 亚洲色图综合在线观看| 99国产精品免费福利视频| 国产精品免费大片| 美女中出高潮动态图| 久久精品久久久久久噜噜老黄| 建设人人有责人人尽责人人享有的| 久久精品国产亚洲av高清一级| 色播在线永久视频| 国产一区二区激情短视频 | 中文字幕高清在线视频| 色94色欧美一区二区| 黄色a级毛片大全视频| 免费看不卡的av| 久久久精品免费免费高清| 欧美日韩一级在线毛片| 国产欧美日韩一区二区三区在线| 精品熟女少妇八av免费久了| 国产欧美日韩一区二区三区在线| 精品国产乱码久久久久久小说| 欧美日韩黄片免| 欧美日韩成人在线一区二区| 亚洲精品日本国产第一区| 捣出白浆h1v1| 久久久久国产一级毛片高清牌| 亚洲午夜精品一区,二区,三区| 80岁老熟妇乱子伦牲交| 天天躁夜夜躁狠狠久久av| www.熟女人妻精品国产| 欧美成人精品欧美一级黄| 精品少妇黑人巨大在线播放| 宅男免费午夜| 日本a在线网址| 中文字幕色久视频| 女人爽到高潮嗷嗷叫在线视频| 老司机靠b影院| h视频一区二区三区| 性高湖久久久久久久久免费观看| 汤姆久久久久久久影院中文字幕| 黄色毛片三级朝国网站| 免费少妇av软件| 亚洲激情五月婷婷啪啪| 亚洲成人手机| 亚洲欧美色中文字幕在线| 天天躁夜夜躁狠狠久久av| 校园人妻丝袜中文字幕| 国产xxxxx性猛交| 亚洲熟女精品中文字幕| 五月天丁香电影| 国产91精品成人一区二区三区 | 亚洲精品久久久久久婷婷小说| 久久热在线av| 成人国产一区最新在线观看 | 亚洲中文日韩欧美视频| 亚洲自偷自拍图片 自拍| 亚洲综合色网址| 人妻一区二区av| 成人午夜精彩视频在线观看| 免费观看人在逋| 一区二区三区精品91| 母亲3免费完整高清在线观看| 亚洲天堂av无毛| 成人影院久久| 久久99热这里只频精品6学生| 国产成人av教育| 电影成人av| 国产日韩一区二区三区精品不卡| 制服人妻中文乱码| 国产成人精品久久二区二区免费| 最新在线观看一区二区三区 | 97人妻天天添夜夜摸| 热99国产精品久久久久久7| 青春草视频在线免费观看| 亚洲久久久国产精品| 大香蕉久久网| 母亲3免费完整高清在线观看| 日韩制服骚丝袜av| 亚洲精品av麻豆狂野| 我要看黄色一级片免费的| 久久人人爽人人片av| 久久精品aⅴ一区二区三区四区| 在线看a的网站| 极品人妻少妇av视频| 亚洲欧美日韩高清在线视频 | 多毛熟女@视频| 国产精品成人在线| 桃花免费在线播放| 宅男免费午夜| 91成人精品电影| 母亲3免费完整高清在线观看| 亚洲国产日韩一区二区| 18禁观看日本| 啦啦啦视频在线资源免费观看| 91麻豆精品激情在线观看国产 | 精品卡一卡二卡四卡免费| 真人做人爱边吃奶动态| 蜜桃国产av成人99| 一区福利在线观看| 99国产综合亚洲精品| 日韩大码丰满熟妇| 伦理电影免费视频| 久久久久国产精品人妻一区二区| 精品一品国产午夜福利视频| 亚洲黑人精品在线| 欧美另类一区| a级毛片黄视频| 午夜福利视频在线观看免费| 国产有黄有色有爽视频| av片东京热男人的天堂| 午夜免费鲁丝| 国产成人一区二区在线| 国产99久久九九免费精品| 日本黄色日本黄色录像| 午夜日韩欧美国产| 欧美日韩亚洲综合一区二区三区_| 一本综合久久免费| 国产亚洲精品久久久久5区| av不卡在线播放| 亚洲国产精品一区二区三区在线| 97精品久久久久久久久久精品| 免费看十八禁软件| 精品国产超薄肉色丝袜足j| 最新的欧美精品一区二区| 国产精品国产三级国产专区5o| 国产精品国产三级专区第一集| 国产亚洲av高清不卡| 日韩大码丰满熟妇| 中文字幕制服av| 人人妻,人人澡人人爽秒播 | 天天影视国产精品| 老熟女久久久| 亚洲成av片中文字幕在线观看| 少妇人妻久久综合中文| 男人爽女人下面视频在线观看| 精品国产一区二区三区四区第35| 亚洲国产日韩一区二区| 十分钟在线观看高清视频www| 黄色视频在线播放观看不卡| 午夜免费观看性视频| 美女主播在线视频| 最近手机中文字幕大全| 久久av网站| 久久久久久亚洲精品国产蜜桃av| 一边摸一边做爽爽视频免费| 国产欧美亚洲国产| 可以免费在线观看a视频的电影网站| 亚洲一区中文字幕在线| 欧美黑人欧美精品刺激| 可以免费在线观看a视频的电影网站| 亚洲欧美激情在线| 精品久久久久久久毛片微露脸 | 一级毛片黄色毛片免费观看视频| 久久ye,这里只有精品| 91字幕亚洲| 永久免费av网站大全| 久久热在线av| 精品亚洲乱码少妇综合久久| 久久99一区二区三区| 欧美国产精品一级二级三级| 好男人电影高清在线观看| 女性生殖器流出的白浆| 久久久久国产一级毛片高清牌| 欧美成人午夜精品| 深夜精品福利| 只有这里有精品99| 国产精品免费大片| 久久精品久久久久久久性| 久久av网站| xxx大片免费视频| 国产精品99久久99久久久不卡| av线在线观看网站| 亚洲成av片中文字幕在线观看| 一区二区av电影网| av不卡在线播放| 久久毛片免费看一区二区三区| 亚洲欧美精品自产自拍| 国产视频首页在线观看| 女人被躁到高潮嗷嗷叫费观| 免费观看人在逋| av天堂久久9| www.自偷自拍.com| 欧美精品一区二区大全| 亚洲,一卡二卡三卡| 亚洲精品国产av蜜桃| cao死你这个sao货| 亚洲伊人久久精品综合| 国产成人免费无遮挡视频| 国产野战对白在线观看| 国产精品秋霞免费鲁丝片| 纯流量卡能插随身wifi吗| 爱豆传媒免费全集在线观看| 午夜免费男女啪啪视频观看| 亚洲精品av麻豆狂野| 国产精品av久久久久免费| 97人妻天天添夜夜摸| 青草久久国产| 精品亚洲乱码少妇综合久久| av一本久久久久| 黄色一级大片看看| 欧美精品啪啪一区二区三区 | 操出白浆在线播放| 天天影视国产精品| 校园人妻丝袜中文字幕| 你懂的网址亚洲精品在线观看| 九色亚洲精品在线播放| av福利片在线| 在线亚洲精品国产二区图片欧美| 只有这里有精品99| 久久人人爽人人片av| 啦啦啦啦在线视频资源| 日韩大码丰满熟妇| 我要看黄色一级片免费的| 成在线人永久免费视频| 无限看片的www在线观看| 老司机影院毛片| 好男人视频免费观看在线| 国产又爽黄色视频| 中文字幕色久视频| 亚洲av成人不卡在线观看播放网 | videosex国产| 中国国产av一级| 久久天堂一区二区三区四区| 久久ye,这里只有精品| 午夜福利一区二区在线看| 国产精品三级大全| av欧美777| 一级片'在线观看视频| 亚洲第一av免费看| av又黄又爽大尺度在线免费看| 免费黄频网站在线观看国产| 日韩一卡2卡3卡4卡2021年| 国产爽快片一区二区三区| 精品熟女少妇八av免费久了| 久久久久久人人人人人| 在线观看免费午夜福利视频| 欧美 日韩 精品 国产| 日本一区二区免费在线视频| 中文字幕制服av| 亚洲国产av新网站| 涩涩av久久男人的天堂| 欧美黄色淫秽网站| 国产精品麻豆人妻色哟哟久久| 中文精品一卡2卡3卡4更新| 国产精品香港三级国产av潘金莲 | 日韩 欧美 亚洲 中文字幕| 欧美少妇被猛烈插入视频| 久久天堂一区二区三区四区| 免费av中文字幕在线| 午夜福利一区二区在线看| 成人影院久久| 国产伦理片在线播放av一区| 中国国产av一级| 99热全是精品| 亚洲av电影在线进入| 丝袜美足系列| 黑丝袜美女国产一区| 又黄又粗又硬又大视频| 电影成人av| 日日爽夜夜爽网站| 日韩熟女老妇一区二区性免费视频| 日韩免费高清中文字幕av| a级毛片在线看网站| 一区二区三区激情视频| 一级,二级,三级黄色视频| av不卡在线播放| 交换朋友夫妻互换小说| 久久久久国产精品人妻一区二区| 男女边摸边吃奶| 国产亚洲av高清不卡| 亚洲国产毛片av蜜桃av| 国产男人的电影天堂91| 巨乳人妻的诱惑在线观看| 久久这里只有精品19| √禁漫天堂资源中文www| videos熟女内射| 少妇人妻久久综合中文| 搡老岳熟女国产| 一级片'在线观看视频| avwww免费| 男女国产视频网站| 日本91视频免费播放| 日韩制服骚丝袜av| 日本欧美视频一区| 亚洲人成电影免费在线| 亚洲精品一区蜜桃| 成人国产av品久久久| 国产欧美日韩一区二区三区在线| 黑丝袜美女国产一区| 婷婷色综合www| 欧美xxⅹ黑人| 久久精品亚洲熟妇少妇任你| 亚洲av日韩在线播放| 欧美精品啪啪一区二区三区 | 亚洲欧美日韩另类电影网站| 汤姆久久久久久久影院中文字幕| 午夜激情av网站| 欧美在线一区亚洲| 9191精品国产免费久久| 亚洲中文av在线| 久久精品国产综合久久久| 成人亚洲精品一区在线观看| 50天的宝宝边吃奶边哭怎么回事| 高清视频免费观看一区二区|